Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance.
Yuzo AbeYoshiki MukudaiMai KuriharaAsami HouriJunichiro ChikudaAtsutoshi YasoKosuke KatoToshikazu ShimaneTatsuo ShirotaPublished in: Cell & bioscience (2021)
This study showed that the expression of TPD52 increases in OSCC cells under hypoxia in a HIF-independent manner and plays an important role in the proliferation and survival of the cells in concordance with HIF, suggesting that novel cancer therapeutics might be led by TPD52 suppression.